Richard W. Mott, Chairman of the Board

Principal, Walkabout Consulting 

Mr. Mott is currently a principal in Walkabout Consulting LLC, a management consulting and private equity firm. Mr. Mott most recently served as President and Chief Executive Officer and Director of Kyphon Inc., a NASDAQ-listed global medical device company focused on minimally invasive spinal therapies, through its acquisition by Medtronic, Inc in late 2007. Prior to Kyphon, Mr. Mott held several executive positions at Wilson Greatbatch Technologies, Inc., most recently as Chief Operating Officer, as well as executive operating roles within the Bristol-Myers Squibb Company. Mr. Mott is the previous recipient of the Ernst & Young Entrepreneur of the Year Award and the Frost & Sullivan Technology Leadership of the Year Award. Mr. Mott holds a B.S. in Ceramic Engineering from Alfred University and is a Graduate of Harvard University's Advanced Management Program.

James J. Bochnowski

General Partner, Delphi Ventures 

Mr. Bochnowski founded Delphi Ventures in 1988. His focus is on medical devices and biotechnology. Mr. Bochnowski began investing in medical companies in 1981 after co-founding Technology Venture Investors, a private venture capital partnership. Since 1984, he has focused exclusively on healthcare investments. From 1976 to 1980, Mr. Bochnowski was with Shugart Associates, a venture-backed disk drive company. As President and CEO, he led Shugart to increasing profitability, with annual revenues growing from $13 million to $200 million. Shugart was acquired by Xerox in 1979.

Trained as an aerospace engineer, Mr. Bochnowski served as an Army officer and a missile systems engineer with the U.S. Army Missile Intelligence Directorate, serves on the Board of Overseers of the Hoover Institution at Stanford University and is a member of the Harvard School of Public Health's Health Policy and Management Executive Council. Mr. Bochnowski currently serves on the Boards of Directors of ArKal Medical, Inc., Ascent Healthcare Solutions, Inc., CollaGenex Pharmaecuticals, Inc. (CGPI), ImmuLogic Pharmaceuticals, Inc. (IMUL), Natus Medical, Inc. (BABY), Synaptics, Inc. (SYNA) and SynergEyes, Inc. He holds an M.B.A. with Distinction from Harvard University Graduate School of Business and a B.S. from the Massachusetts Institute of Technology. 

Kerry Dance Ph.D.

Managing Director, Hamilton BioVentures 

Dr. Dance has 25 years of executive experience, both as a scientist and a leader, and has focused on life sciences since the beginning the formation of Hamilton in 1998. Dr. Dance came to San Diego in 1978 and became President of General Atomics Corporation. While at General Atomics he founded an in-house venture enterprise (one of the first in San Diego) which produced a successful track record and spun off several successful enterprises, including the San Diego Super Computer Center. Dr. Kerry Dance currently is the Chairman of the Board of Directors of Angstrom Pharmaceuticals and observes on the Board of Ceregene. Dr. Dance attended Stanford University where he received a Ph.D. in Mechanical Engineering with a Nuclear Option and Math Minor and B.S. and M.S. degrees in Engineering Science.

Noah J. Knauf

Investment Professional, Warburg Pincus 

Mr. Knauf focuses on medical technology as an investment professional at Warburg Pincus. He currently serves on the Boards of Directors of Adlens Beacon, Constitution Medical Investors, Lifecore Biomedical, and Keystone Dental. Prior to joining Warburg Pincus, Mr. Knauf was an Associate at Parthenon Capital, a private equity firm, and a consultant with Bain & Company, a global consulting firm. He holds an M.B.A. from Stanford University Graduate School of Business, where he was an Arjay Miller scholar, and a B.S.B.A. from the University of Arizona.

Jack W. Lasersohn

General Partner, The Vertical Group 

Mr. Lasersohn has over twenty-five years of experience in health care venture capital investments. Prior to joining The Vertical Group's predecessor, F. Eberstadt in 1981, Mr. Lasersohn was a corporate attorney with Cravath, Swaine & Moore. Mr. Lasersohn currently serves on the Boards of Directors of Alsius Corporation, Bacchus Vascular, Inc., Kyphon Inc., Masimo Corporation, Metabolix, Inc., Oncomed, Photothera, Proteolix , Timi3 Systems, Inc. and TetraLogic Pharmaceuticals. He previously served on the boards of CardioThoracic Systems, Inc., Cardiovascular Imaging Systems, Inc., and E.P. Technologies. Mr. Lasersohn received a B.S. degree in Physics from Tufts University, an M.A. from The Fletcher School of Law and Diplomacy, and a J.D. from Yale Law School.

Arthur T. Taylor

President and CEO, PhotoThera, Inc. 

Mr. Taylor most recently served as Vice President and General Manager for the Kyphon Products, Spinal & Biologics Business of Medtronic, Inc. Prior to Medtronic’s acquisition of Kyphon in late 2007, Mr. Taylor served as Kyphon’s Chief Operating Officer from 2006, and as Chief Financial Officer from 2004 through 2006. Prior to his Kyphon tenure, Mr. Taylor gained in-depth experience across the medical device industry while serving as Chief Financial Officer for ReSound Corporation, a hearing healthcare company, and in executive positions with Allergan, Inc. and American Hospital Supply Corporation. Mr. Taylor holds a B.S. in Corporate Finance from San Diego State University and an M.B.A. from the University of Southern California.   

Elizabeth H. Weatherman

Managing Director, Warburg Pincus